CU Boulder researchers have developed a potent, drug-like compound that could someday revolutionize treatment of rheumatoid arthritis and other autoimmune diseases.
Days after Shalane Flanagan won the NYC Marathon, CU Boulder researchers have published a study that inspired the name of the shoes she wore and confirms they reduce the amount of energy used to run.
The research initiative will establish best practices and clinical infrastructure for advancing education on traumatic brain injury in student-athletes.
Facebook, Twitter, and other social media platforms are becoming tools for tracking flu, Zika and other illnesses, signaling looming epidemics faster than public health agencies once could.
The influenza A virus kills 12,000 to 56,000 people in the U.S. annually, but a newly discovered mechanism by which the human immune system tries to battle the virus could lead to new treatments.
With their brains, sleep patterns and eyes still developing, children and adolescents are particularly vulnerable to the sleep-disrupting effects of screen time. Watch a short video interview.
While traffic stops and arrests have fallen in nonwhite areas of Ferguson, Missouri, crime rates remain steady, suggesting cops previously had been "over-policing" these areas.
Researchers are studying 5,000 twins to paint a more accurate picture of how marijuana use changes as a result of legalization and how those changes may impact health in the long run.
Light-activated nanoparticles, also known as quantum dots, can provide a crucial boost in effectiveness for antibiotic treatments used to combat drug-resistant superbugs such as E. coli and Salmonella.
